Department of Social Work, Augsburg College, Minneapolis, Minnesota 55454, USA.
Soc Work Public Health. 2012;27(3):238-49. doi: 10.1080/19371918.2011.542975.
The Medicare prescription drug benefit, introduced in January 2006, has had a substantial impact on the lives of adults disabled by mental illness. However, few studies have undertaken an exploration of the difference that this benefit has made to beneficiaries' access to medication. This study uses a qualitative approach to examine beneficiaries' experiences with the Medicare Part D benefit, and whether having Medicare prescription drug coverage is perceived as helpful. Twenty-six Medicare beneficiaries with mental illness were interviewed regarding their opinions of the Part D benefit, and the investigator found that most beneficiaries were highly satisfied with their prescription drug coverage. However, they would appreciate more information from the Medicare program about their benefits. In addition, beneficiaries were concerned about the possibility of increased future costs. Overall, however, these participants in the Medicare Part D program who had mental illness felt that their needs for psychotropic and other medications were met.
医疗保险处方药福利于 2006 年 1 月推出，对精神疾病残疾成年人的生活产生了重大影响。然而，很少有研究探讨这项福利对受益人获得药物的影响。本研究采用定性方法，调查了受益人的医疗保险 D 部分福利的使用情况，以及是否认为医疗保险处方药覆盖范围有所帮助。对 26 名患有精神疾病的医疗保险受益人进行了采访，询问他们对 D 部分福利的看法，调查人员发现，大多数受益人对他们的处方药报销非常满意。然而，他们希望从医疗保险计划中获得更多有关其福利的信息。此外，受益人还担心未来费用增加的可能性。然而，总体而言，这些参加医疗保险 D 部分计划的患有精神疾病的参与者认为他们对精神药物和其他药物的需求得到了满足。
